(Q77295513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

[Clinical effects of 5-aminosalicylic acid preparations in Crohn disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

W E Fleig

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

94 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

22-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group

4 December 2019

cites work

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

1 reference

12 December 2020

Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group

1 reference

12 December 2020

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

1 reference

12 December 2020

Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis

1 reference

12 December 2020

Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables

1 reference

12 December 2020

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment

1 reference

12 December 2020

[Therapy of Crohn diseases--results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases]

1 reference

12 December 2020

Predictability of the postoperative course of Crohn's disease

1 reference

12 December 2020

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

12 December 2020

Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03042029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194944%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference